N
LLY icon

Nuveen’s Eli Lilly LLY Stock Holding History

Nuveen’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-10,300
Closed -$3K – 3385
2022
Q1 		$3K Buy
+10,300
New +$2.65M ﹤0.01% 3361
2021
Q2 		– Sell
-25,700
Closed -$5K – 3461
2021
Q1 		$5K Buy
+25,700
New +$5.03M ﹤0.01% 3330

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Nuveen's LLY Position: Q1 2026 in Review

Nuveen reduced its Eli Lilly (LLY) stake by 1.8% in Q1 2026, selling an estimated $98.2M and leaving 5,337,672 shares worth $4.91B. The position accounts for 1.33% of the portfolio, ranked #10.

Nuveen first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.84B in Q4 2025. 4,363 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Nuveen held 5,337,672 shares of Eli Lilly worth $4.91B as of Q1 2026.
  • Nuveen sold 96,900 Eli Lilly shares in Q1 2026, an estimated $98.2M.
  • Eli Lilly made up 1.33% of Nuveen's portfolio in Q1 2026, its #10 holding.
  • Nuveen first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Nuveen's Eli Lilly position peaked at $5.84B in Q4 2025.
  • 4,363 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.